NSE: BIOCON - Biocon Limited

Yield per half year: +2.38%
Sector: Healthcare

Biocon Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
29.52 59.64 -50.5% 53.78 -45.1%
P/S 2.05 9.32 -78.06%
P/BV 1.19 6.64 -82.02%
P/FCF 29.28 -14.63 -300.14%
Ev/Ebitda 10.89 141.59 -92.31%
Ev/S 3.07 9.59 -68.05%
Ev/FCF 44.24 -85.24 -151.9%
E/P 0.0342 0.0857 -60.11%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
28.14 5.56 406.05% 25.81 +9.03%
ROE 5.43 10.72 -49.36%
ROA 1.89 7.64 -75.23%
ROIC 1.86 15.91 -88.34%
ROS 6.93 -4.5 -253.99%
ROCE 6.35 13.25 -52.11%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
3/10
3.92 122.67 -96.8% 3.49 +12.16%
Nеt Debt/Ebitda 3.62 121.47 -97.02%
Debt/Ratio 0.2903 0.145 100.13%
Debt/Equity 1.61 1.81 -11.26%
Debt/Net Income 15.92 5.06 214.46%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
1.05/10
0.4194 9.55 -95.61% 0.2026 +106.99%
Number of years of dividend growth 0 0.7317 -100%
DSI 0.9286 0.8351 11.2%
Average dividend growth -11.11 -3.25 241.93%
Average percentage for 5 years 0.2026 14.84 -98.63%
Average percentage for payments 26.9 24.67 9.06%
Difference from average difference in sector -9.14

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
137.55 42.49 223.72%
Growth impulse Ebitda in 5 years 140.27 70.55 98.82%
Growth impulse Net Income in 5 years 36.66 77.88 -52.93%
Growth impulse FCF in 5 years -284.73 -25 1038.92%
Growth impulse EPS in 5 years 34.54 48.34 -28.55%
IP Score
4.52/10

Similar companies

Apollo Hospitals Enterprise Limited

IndusInd Bank Limited

Divi's Laboratories Limited

Torrent Pharmaceuticals Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription